Failure rates in clinical trials oncology
Oncology Clinical Trial Failure Rates.
It is interesting to read this report and see the percentages of successful drugs that enter clinical trials that are approved for use at the end of Phase 3 trials.
I don't know what percentage of these trials used the human form of cancer when conducting experiments on mice. We know the in the case of TLT, they have been using human cancer cells. Whether that makes TLT's product any more likely to be successful, I don't know.
It will be interesting as we go forward. We have a higher probability of failure than success. But I know we are all rooting for a win here. A win for cancer patients and a win for our bank accounts.